It was found that the elevated expression of IGF2BP3 can foster the growth of hepatocellular carcinoma by regulating macrophage infiltration in the tumor microenvironment, promoting M2-type polarization, and inhibiting CD8+ T-cell activation, thus weakening the anti-tumor immune response [31]. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.